List of Tables
Table 1. Global Biosimilars of Rituximab Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Biosimilars of Rituximab Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Biosimilars of Rituximab Market Competitive Situation by Manufacturers in 2024
Table 4. Global Biosimilars of Rituximab Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Biosimilars of Rituximab Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Biosimilars of Rituximab Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Biosimilars of Rituximab Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Biosimilars of Rituximab Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Biosimilars of Rituximab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biosimilars of Rituximab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biosimilars of Rituximab, Product Type & Application
Table 12. Global Key Manufacturers of Biosimilars of Rituximab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biosimilars of Rituximab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars of Rituximab as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosimilars of Rituximab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Biosimilars of Rituximab Sales by Region (2020-2025) & (K Units)
Table 18. Global Biosimilars of Rituximab Sales Market Share by Region (2020-2025)
Table 19. Global Biosimilars of Rituximab Sales by Region (2026-2031) & (K Units)
Table 20. Global Biosimilars of Rituximab Sales Market Share by Region (2026-2031)
Table 21. Global Biosimilars of Rituximab Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Biosimilars of Rituximab Revenue Market Share by Region (2020-2025)
Table 23. Global Biosimilars of Rituximab Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Biosimilars of Rituximab Revenue Market Share by Region (2026-2031)
Table 25. North America Biosimilars of Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Biosimilars of Rituximab Sales by Country (2020-2025) & (K Units)
Table 27. North America Biosimilars of Rituximab Sales by Country (2026-2031) & (K Units)
Table 28. North America Biosimilars of Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Biosimilars of Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Biosimilars of Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Biosimilars of Rituximab Sales by Country (2020-2025) & (K Units)
Table 32. Europe Biosimilars of Rituximab Sales by Country (2026-2031) & (K Units)
Table 33. Europe Biosimilars of Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Biosimilars of Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Biosimilars of Rituximab Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Biosimilars of Rituximab Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Biosimilars of Rituximab Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Biosimilars of Rituximab Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Biosimilars of Rituximab Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biosimilars of Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Biosimilars of Rituximab Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Biosimilars of Rituximab Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Biosimilars of Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biosimilars of Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Biosimilars of Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Biosimilars of Rituximab Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Biosimilars of Rituximab Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Biosimilars of Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Biosimilars of Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Biosimilars of Rituximab Sales (K Units) by Type (2020-2025)
Table 51. Global Biosimilars of Rituximab Sales (K Units) by Type (2026-2031)
Table 52. Global Biosimilars of Rituximab Sales Market Share by Type (2020-2025)
Table 53. Global Biosimilars of Rituximab Sales Market Share by Type (2026-2031)
Table 54. Global Biosimilars of Rituximab Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Biosimilars of Rituximab Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Biosimilars of Rituximab Revenue Market Share by Type (2020-2025)
Table 57. Global Biosimilars of Rituximab Revenue Market Share by Type (2026-2031)
Table 58. Global Biosimilars of Rituximab Price (US$/Unit) by Type (2020-2025)
Table 59. Global Biosimilars of Rituximab Price (US$/Unit) by Type (2026-2031)
Table 60. Global Biosimilars of Rituximab Sales (K Units) by Application (2020-2025)
Table 61. Global Biosimilars of Rituximab Sales (K Units) by Application (2026-2031)
Table 62. Global Biosimilars of Rituximab Sales Market Share by Application (2020-2025)
Table 63. Global Biosimilars of Rituximab Sales Market Share by Application (2026-2031)
Table 64. Global Biosimilars of Rituximab Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Biosimilars of Rituximab Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Biosimilars of Rituximab Revenue Market Share by Application (2020-2025)
Table 67. Global Biosimilars of Rituximab Revenue Market Share by Application (2026-2031)
Table 68. Global Biosimilars of Rituximab Price (US$/Unit) by Application (2020-2025)
Table 69. Global Biosimilars of Rituximab Price (US$/Unit) by Application (2026-2031)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Amgen Biosimilars of Rituximab Product
Table 74. Amgen Recent Developments/Updates
Table 75. AryoGen Pharmed Company Information
Table 76. AryoGen Pharmed Description and Business Overview
Table 77. AryoGen Pharmed Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AryoGen Pharmed Biosimilars of Rituximab Product
Table 79. AryoGen Pharmed Recent Developments/Updates
Table 80. Biocad Company Information
Table 81. Biocad Description and Business Overview
Table 82. Biocad Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Biocad Biosimilars of Rituximab Product
Table 84. Biocad Recent Developments/Updates
Table 85. Cadila Pharmaceuticals Company Information
Table 86. Cadila Pharmaceuticals Description and Business Overview
Table 87. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cadila Pharmaceuticals Biosimilars of Rituximab Product
Table 89. Cadila Pharmaceuticals Recent Developments/Updates
Table 90. Celltrion Company Information
Table 91. Celltrion Description and Business Overview
Table 92. Celltrion Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Celltrion Biosimilars of Rituximab Product
Table 94. Celltrion Recent Developments/Updates
Table 95. Dr Reddy’s Laboratories Company Information
Table 96. Dr Reddy’s Laboratories Description and Business Overview
Table 97. Dr Reddy’s Laboratories Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Dr Reddy’s Laboratories Biosimilars of Rituximab Product
Table 99. Dr Reddy’s Laboratories Recent Developments/Updates
Table 100. Teva Company Information
Table 101. Teva Description and Business Overview
Table 102. Teva Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Biosimilars of Rituximab Product
Table 104. Teva Recent Developments/Updates
Table 105. Hetero Group Company Information
Table 106. Hetero Group Description and Business Overview
Table 107. Hetero Group Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hetero Group Biosimilars of Rituximab Product
Table 109. Hetero Group Recent Developments/Updates
Table 110. Innovent Biologics Company Information
Table 111. Innovent Biologics Description and Business Overview
Table 112. Innovent Biologics Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Innovent Biologics Biosimilars of Rituximab Product
Table 114. Innovent Biologics Recent Developments/Updates
Table 115. Intas Biopharmaceuticals Company Information
Table 116. Intas Biopharmaceuticals Description and Business Overview
Table 117. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Intas Biopharmaceuticals Biosimilars of Rituximab Product
Table 119. Intas Biopharmaceuticals Recent Developments/Updates
Table 120. Viatris Company Information
Table 121. Viatris Description and Business Overview
Table 122. Viatris Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Viatris Biosimilars of Rituximab Product
Table 124. Viatris Recent Developments/Updates
Table 125. Probiomed Company Information
Table 126. Probiomed Description and Business Overview
Table 127. Probiomed Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Probiomed Biosimilars of Rituximab Product
Table 129. Probiomed Recent Developments/Updates
Table 130. TRPharma Company Information
Table 131. TRPharma Description and Business Overview
Table 132. TRPharma Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. TRPharma Biosimilars of Rituximab Product
Table 134. TRPharma Recent Developments/Updates
Table 135. Zenotech Laboratories Company Information
Table 136. Zenotech Laboratories Description and Business Overview
Table 137. Zenotech Laboratories Biosimilars of Rituximab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Zenotech Laboratories Biosimilars of Rituximab Product
Table 139. Zenotech Laboratories Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Biosimilars of Rituximab Distributors List
Table 143. Biosimilars of Rituximab Customers List
Table 144. Biosimilars of Rituximab Market Trends
Table 145. Biosimilars of Rituximab Market Drivers
Table 146. Biosimilars of Rituximab Market Challenges
Table 147. Biosimilars of Rituximab Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biosimilars of Rituximab
Figure 2. Global Biosimilars of Rituximab Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilars of Rituximab Market Share by Type: 2024 & 2031
Figure 4. 500mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Other Product Picture
Figure 7. Global Biosimilars of Rituximab Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Biosimilars of Rituximab Market Share by Application: 2024 & 2031
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Global Biosimilars of Rituximab Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biosimilars of Rituximab Market Size (2020-2031) & (US$ Million)
Figure 13. Global Biosimilars of Rituximab Sales (2020-2031) & (K Units)
Figure 14. Global Biosimilars of Rituximab Average Price (US$/Unit) & (2020-2031)
Figure 15. Biosimilars of Rituximab Report Years Considered
Figure 16. Biosimilars of Rituximab Sales Share by Manufacturers in 2024
Figure 17. Global Biosimilars of Rituximab Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Biosimilars of Rituximab Players: Market Share by Revenue in Biosimilars of Rituximab in 2024
Figure 19. Biosimilars of Rituximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Biosimilars of Rituximab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Biosimilars of Rituximab Sales Market Share by Country (2020-2031)
Figure 22. North America Biosimilars of Rituximab Revenue Market Share by Country (2020-2031)
Figure 23. United States Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Biosimilars of Rituximab Sales Market Share by Country (2020-2031)
Figure 26. Europe Biosimilars of Rituximab Revenue Market Share by Country (2020-2031)
Figure 27. Germany Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Biosimilars of Rituximab Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Biosimilars of Rituximab Revenue Market Share by Region (2020-2031)
Figure 34. China Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Biosimilars of Rituximab Sales Market Share by Country (2020-2031)
Figure 44. Latin America Biosimilars of Rituximab Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Biosimilars of Rituximab Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Biosimilars of Rituximab Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Biosimilars of Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Biosimilars of Rituximab by Type (2020-2031)
Figure 54. Global Revenue Market Share of Biosimilars of Rituximab by Type (2020-2031)
Figure 55. Global Biosimilars of Rituximab Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Biosimilars of Rituximab by Application (2020-2031)
Figure 57. Global Revenue Market Share of Biosimilars of Rituximab by Application (2020-2031)
Figure 58. Global Biosimilars of Rituximab Price (US$/Unit) by Application (2020-2031)
Figure 59. Biosimilars of Rituximab Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
